Literature DB >> 1688621

Detection of SIV antigens by HIV-1 antigen capture immunoassays.

S Goldstein1, R Engle, R A Olmsted, V M Hirsch, P R Johnson.   

Abstract

We tested three commercially available HIV-1 antigen capture systems for their ability to detect simian immunodeficiency viruses (SIV). All three kits detected antigens from six distinct SIV isolates, but with varying degrees of sensitivity. For the overall detection of SIV in cell culture, our assay for reverse transcriptase was more sensitive than HIV-1 antigen capture. HIV-1 antigen capture systems were useful for the detection of SIV antigenemia in experimentally infected macaques. The limited sensitivity of HIV-1-specific antigen capture suggests that SIV-specific antigen capture reagents should be developed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688621

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  4 in total

1.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

2.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection.

Authors:  Greg Brennan; Michael D Podell; Raymund Wack; Susan Kraft; Jennifer L Troyer; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

4.  Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.

Authors:  C M Hill; H Deng; D Unutmaz; V N Kewalramani; L Bastiani; M K Gorny; S Zolla-Pazner; D R Littman
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.